miR-16 promotes the apoptosis of human cancer cells by targeting FEAT

BMC Cancer

Volumn 15, Issue 1, 2015, Pages

  Liang, Hongwei ^a   Fu, Zheng ^a   Jiang, Xueyuan ^a,c   Wang, Nan ^a   Wang, Feng ^b   Wang, Xueliang ^a   Zhang, Suyang ^a   Wang, Yanbo ^a   Yan, Xin ^b   Guan, Wen xian ^b   Zhang, Chen Yu ^a   Zen, Ke ^a   Zhang, Yujing ^a   Chen, Xi ^a   Zhou, Guangxin ^a  

^a NANJING UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Apoptosis; FEAT; miR 16

Indexed keywords

FEAT PROTEIN; MICRORNA 16; PEPTIDES AND PROTEINS; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; FEAT PROTEIN, HUMAN; METHYLTRANSFERASE; MICRORNA; MIRN16 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; A549 CELL LINE; APOPTOSIS; ARTICLE; BIOINFORMATICS; BREAST CANCER; CANCER CELL; CANCER CELL LINE; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEAT GENE; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUH 7 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CANCER; LUCIFERASE ASSAY; LUNG CANCER; MCF 7 CELL LINE; PLASMID; PROTEIN EXPRESSION; PROTEIN RNA BINDING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING; BIOLOGY; BREAST TUMOR; GENETICS; LIVER CELL CARCINOMA; LIVER TUMOR; LUNG TUMOR; MCF-7 CELL LINE; METABOLISM;

3' UNTRANSLATED REGIONS; APOPTOSIS; BREAST NEOPLASMS; CARCINOMA, HEPATOCELLULAR; COMPUTATIONAL BIOLOGY; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MCF-7 CELLS; METHYLTRANSFERASES; MICRORNAS; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84930647629     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-015-1458-8     Document Type: Article

References (23)

1. Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature. 2009;458(7239):719-24.
2. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-74.
3. Takahashi A, Tokita H, Takahashi K, Takeoka T, Murayama K, Tomotsune D, et al. A novel potent tumour promoter aberrantly overexpressed in most human cancers. Sci Rep. 2011;1:15.
4. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281-97.
5. Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350-5.
6. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5(7):522-31.
7. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer. 2006;6(4):259-69.
8. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857-66.
9. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002;99(24):15524-9.
10. Aqeilan RI, Calin GA, Croce CM. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ. 2010;17(2):215-20.
11. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proceedings of the National Academy of Sciences of the United States of America. 2005;102(39):13944-9.
12. Linsley PS, Schelter J, Burchard J, Kibukawa M, Martin MM, Bartz SR, et al. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol. 2007;27(6):2240-52.
13. Liu Q, Fu H, Sun F, Zhang H, Tie Y, Zhu J, et al. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res. 2008;36(16):5391-404.
14. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, et al. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med. 2008;14(11):1271-7.
15. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med. 2005;353(17):1793-801.
16. Bandi N, Zbinden S, Gugger M, Arnold M, Kocher V, Hasan L, et al. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res. 2009;69(13):5553-9.
17. Chen X, Guo X, Zhang H, Xiang Y, Chen J, Yin Y, et al. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene. 2009;28(10):1385-92.
18. Hsu SD, Tseng YT, Shrestha S, Lin YL, Khaleel A, Chou CH, et al. miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions. Nucleic acids research. 2014;42(Database issue):D78-85.
19. Altermann E, Klaenhammer TR: PathwayVoyager: pathway mapping using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. Bmc Genomics. 2005;6:60.
20. Tabas-Madrid D, Nogales-Cadenas R, Pascual-Montano A. GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics. Nucleic acids research. 2012;40(Web Server issue):W478-483.
21. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell. 2003;115(7):787-98.
22. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human MicroRNA targets. PLoS Biol. 2004;2(11):e363.
23. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, et al. Combinatorial microRNA target predictions. Nat Genet. 2005;37(5):495-500.